We’re experiencing issues for some mobile devices with our ARTG dataset filter function. We apologise for any inconvenience while we work to fix this.
Notice for selinexor (Antengene (AUS) Pty Ltd)
Active ingredients
selinexor
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
film-coated tablet
Indication
For the treatment of diffuse large B-Cell lymphoma
Therapeutic area
Haematology